Joseph A. Aloi

Dr. Joseph A. Aloi is a Professor in the Department of Endocrinology and Metabolism at Wake Forest University School of Medicine. He serves as Section Chief for Endocrinology and Metabolism at Wake Forest Baptist Health, focusing on clinical research in thyroid cancer and technology-driven diabetes management.

• MD from George Washington University (1988)
• Residency in Internal Medicine at University of Virginia Medical Center (1991)
• Fellowship in Endocrinology at University of Virginia Medical Center (1994)

Research Interests: Dr. Aloi's work spans thyroid cancer epidemiology and the application of technology in diabetes care, including hybrid closed-loop systems and computer-guided insulin dosing. His recent publications address diabetes complications in hospitalized patients and metabolic outcomes in endocrine disorders.

Scientific Contributions: His 2021 JAMA Network Open study analyzed diabetic ketoacidosis mortality during the pandemic, while earlier work in Diabetes Care and Theranostics explored drug safety and stem cell regeneration in diabetic nephropathy.

• Scientific Awards: Not explicitly mentioned in text

Clinical Leadership: Dr. Aloi leads the Endocrinology and Metabolism section and maintains active clinical practice at Wake Forest Baptist Diabetes and Endocrinology Center, with 127 patient reviews averaging 4.9/5.0.